Skip to main content

and
  1. No Access

    Article

    Impact of weight loss on treatment with PD-1/PD-L1 inhibitors plus chemotherapy in advanced non-small-cell lung cancer

    Programmed cell death-1 (PD-1)/programmed death-ligand 1 (PD-L1) inhibitors plus chemotherapy have become the standard first line of treatment in patients with advanced non-small-cell lung cancer (NSCLC). Howe...

    Taichi Miyawaki, Tateaki Naito, Michitoshi Yabe in Supportive Care in Cancer (2022)

  2. No Access

    Article

    Clinical impact of walking capacity on the risk of disability and hospitalizations among elderly patients with advanced lung cancer

    Little is known about the impact of decreased walking capacity on clinical outcomes in elderly patients with cancer. This prospective observational study aimed to investigate the impact of walking capacity on ...

    Taro Okayama, Tateaki Naito, Yusuke Yonenaga, Takuya Ohashi in Supportive Care in Cancer (2021)